Latest stories on TVRD
Tvardi Therapeutics Expands At-The-Market Equity Program
TipRanks28 · bearishgeneral
Tvardi Therapeutics, Inc. (TVRD) files 8-K
SEC 8-K50 · neutralgeneral
Why Is Penny Stock Tvardi Therapeutics (TVRD) Up Today?
TipRanks67 · bullishanalyst
Tvardi’s TTI-109 Phase 1 Data Shows Up to 60% Immune Cell Reduction and Superior Tolerability Over TTI-101
MarketChameleon63 · neutralproduct/pr
TTI-109 Phase 1 Results Show Meaningful Reductions in STAT3-Driven Immune Cells—Path Cleared for Dermatologic and GI Trials Pending Funding
MarketChameleon67 · bullishproduct/pr
Tvardi Therapeutics Reports Phase 1 Data for TTI-109
TipRanks59 · neutralproduct/pr
Tvardi Therapeutics, Inc. (TVRD) files 8-K
SEC 8-K50 · neutralgeneral
Tvardi Therapeutics, Inc. (TVRD) files 8-K
SEC 8-K50 · neutralgeneral
Ocugen, Assertio among healthcare stocks set to join Russell Microcap; Definium Therapeutics, Tvardi Therapeutics to exit
Seeking Alpha50 · neutralgeneral
Tvardi Therapeutics to Participate in Upcoming Investor Events | TVRD Stock News
StockTitan56 · neutralgeneral